Surviving sepsis--practice guidelines, marketing campaigns, and Eli Lilly.

Correction: Is the Current Management of Severe Sepsis and Septic Shock Really Evidence Based?

The competing interests statement was incomplete and should have read: “Jean-Louis Vincent is the current chairman of the International Sepsis Forum, and a member of the steering committee of the Surviving Sepsis Campaign. His personal views do not necessarily refl ect those of the other members of these committees. The Surviving Sepsis Campaign has received funding from Eli Lilly, Baxter, and ...

Regulating Direct-to-Consumer Drug Information: A Case Study of Eli Lilly's Canadian 40over40 Erectile Dysfunction Campaign.

Like most jurisdictions, Canada prohibits direct-to-consumer advertising (DTCA) of prescribed drugs. However, direct-to-consumer information (DTCI) is permitted, allowing companies to inform the public about medical conditions. An analysis of Eli Lilly's 40over40 promotion campaign for erectile dysfunction (ED), which included a quiz on ED, shows that DTCI, like DTCA, can be an effective means ...

New clinical practice guidelines of the surviving sepsis campaign: a critical appraisal.

In 2004 was published the first edition of the "Surviving sepsis campaign" guidelines for the management of severe sepsis and septic shock, opening a new era in the treatment of this syndrome. The paradox is that guidelines application have produced positive results despite including in some cases treatments proven ineffective. Eight years later has been published the third edition of the guide...

SCIENTIFIC DISCUSSION Invented name of the medicinal product: Zyprexa Marketing Authorisation Holder:

New clinical practice guidelines of the surviving sepsis campaign: A critical appraisal